A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
According to the health department’s recent report, among the 2,394 HIV-positive individuals in Mau, 1,147 are men, 1,151 are women, and 85 are children.
3d
Daily Maverick on MSNUS funding cuts imperil African search for HIV vaccineA groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the US government. As a result, several promising vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results